Articles tagged with Organoids
Dr. Paola Arlotta's groundbreaking research on stem cell-derived brain organoids has redefined human brain development and neurological disease understanding. Her work provides access to the complexities of developing human brains, making her a deserving recipient of the ISSCR Momentum Award.
Researchers from Flinders University applied gene editing to explore the role of enzyme ACE2 in healthy placental development. They found that ACE2 plays a key role in helping cells grow properly and that a genetic variation is linked to major pregnancy complications.
Scientists at German Cancer Research Center develop innovative method for growing individual brain tumors in lab, mimicking original structure and molecular properties. The IPTO model accurately predicts patient response to chemotherapy and other drugs, offering a valuable tool for personalized medicine.
The ISSCR International Symposium will commemorate the 20th anniversary of iPSC discovery, highlighting breakthrough achievements and new research advances. The event aims to celebrate the transformative power of scientific curiosity and its potential to unlock cures for previously untreatable diseases.
Researchers at Mayo Clinic developed patient-derived organoid models to study uveal melanoma, a common type of eye cancer. These 3D models accurately represent the disease's genetic and biological characteristics, enabling better understanding and treatment development.
A new AI-powered software, EmbryoNet, can automatically detect defects in animal embryos and link them to underlying signalling pathways. This technology has the potential to replace lengthy animal studies in drug research, speeding up conventional processes while reducing costs significantly.
The KAIST research team developed a highly stretchable microelectrode array to monitor organoids' functions, enabling real-time analysis of their states. The technology showed promise in high-throughput drug screening applications, revealing changes in signal characteristics according to size and identifying potential drug interactions.
A novel patient-derived organoid library of tongue cancer tissue samples reveals new insights into chemoresistance mechanisms, highlighting the importance of autophagy and cholesterol biosynthesis pathways. The research also identifies potential drug targets for overcoming chemotherapy resistance in tongue cancer.
Organoids, derived from stem cells, closely mimic human tissue for biomedical research and drug testing. Standardization is crucial for generating reliable results in organoid construction, requiring approved operating procedures and informed consent from donors.
Researchers have developed a new way to grow organoids using Invasin, a protein produced by bacteria, mimicking the original organ with its variety of cell types. This study provides an affordable, standardized and animal-free alternative to currently used methods.
Researchers at TUM have grown tumor organoids that reproduce the morphological complexity of pancreatic cancer cells in the laboratory. The team used machine learning to categorize the organoids into different phenotypes based on their appearance and behavior, which react differently to treatments.
Researchers used lab-grown organoids from glioblastoma tumors to model patient response to CAR T cell therapy. The organoids accurately reflected the treatment's effect on actual tumors, providing a promising tool for personalized medicine.
Researchers developed a deep-learning model to predict organoid development at an early stage, outperforming human experts in accuracy and speed. The model classifies bright-field images of organoids into three quality categories, indicating their potential for regenerative medicine applications.
A Virginia Tech researcher has received a collaborative grant to improve cancer therapies by developing 3D liver organoids and employing cutting-edge microscopy technology. The project aims to identify the most effective treatments for cancer, enabling better-targeted treatments.
Scientists have developed a new organoid that includes all three key cell types in the pancreas, allowing for a clearer understanding of its early development. The research discovered a new stem cell type that can develop into these cells, and found differences between human and mouse pancreatic development.
Researchers at ISTA used miniature 2D organs and rubbery silicone molds to study morphogen signaling dynamics during spinal cord development. The study found that BMP morphogen signaling gradients emerge quickly, then fade away, only to reappear again, shedding light on the complex process of tissue development.
Researchers developed a platform to produce mature, uniform organoids using a three-dimensional engineered membrane. This breakthrough enables consistent quality and improved efficiency for practical applications in clinical trials and drug development.
Researchers created tiny lab-grown models of human immune systems to study immune function in cancer and predict disease treatment response. The miniature models support longer cell function, allowing processes like antibody formation to occur similar to the human body.
The SpaceX CRS-31 mission to the International Space Station includes studies on in-space manufacturing, cardiac health, and a method for repairing spacecraft damaged by debris. Multiple payloads sponsored by the ISS National Laboratory are bound for the orbiting outpost.
The IGFBP3 protein plays a crucial role in human lung development, and its expression must be reduced for cell differentiation to take place. The study used organoids derived from embryonic lungs to simulate lung development and found that IGFBP3 helps maintain lung epithelial cells in an undifferentiated state.
A team of researchers has developed strategies to identify regulators of intestinal hormone secretion, which could lead to new treatments for metabolic and gut motility disorders. They used human organoids to study the function of 'nutrient sensors' on hormone-producing cells in the gut.
Researchers at EPFL have developed the e-Flower, a flower-shaped 3D microelectrode array that enables real-time recording of neural activity from 3D neural spheroids. This breakthrough technology allows for more accurate and gentle monitoring of brain cells, paving the way for further research on brain organoids.
Researchers created a single cell atlas of prenatal human skin, providing a molecular recipe for building skin. The study also led to the creation of a mini organ model that grows hair, offering insights into scarless skin repair and potential clinical applications in regenerative medicine.
A Korean research team has successfully observed living organoids in real time at a high resolution using holotomography. The technology allows for long-term observation of dynamic changes and precise analysis of organoid responses to drug treatments.
Researchers at Texas Biomedical Research Institute developed a human cell culture model of alveolar macrophages, which helped make a key finding about the role of tumor necrosis factor (TNF) in tuberculosis (TB). The study found that TNF is critical to protect against TB but not other infectious diseases.
Organoids are miniature organs that capture specific organ structures and functions. They have been shown to shed light on genetic cell fates in various diseases, including infectious diseases, metabolic disorders, and malignancies.
Researchers found inhibiting ACMSD increases NAD+ levels, reducing inflammation and fibrosis in mouse models of MASLD/MASH. Boosting NAD+ production could protect against severe liver damage and cirrhosis.
Researchers from the Hubrecht Institute found that tuft cells can proliferate and generate new epithelial cell types, restoring damaged gut tissue. This discovery may have important implications for regenerative medicine.
Researchers have developed a lab-grown spine model that can test the effects of valproic acid on fetal development. The study found that co-treatment with Rapamycin can prevent the negative effects of valproic acid, enabling women to take life-saving medication while having healthy children.
Researchers at University of California - San Diego have discovered that Crohn's disease consists of two distinct molecular subtypes, each exhibiting unique patterns of genetic mutation and cellular phenotypes. This finding could lead to more effective management strategies, with therapies tailored to specific subtypes.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center developed a biobank of 294 samples from 126 patients with 25 different subtypes of bone and soft tissue sarcoma. The team created tumor organoids that retained key characteristics of the original tumors, which were then subjected to high-throughput drug screening. They iden...
The Harvard team successfully recreated the satellite cell niche using 3D organoid culture techniques, generating stem cells that closely resemble native adult stem cells. These cells can engraft, repopulate the stem cell niche, persist long-term, and regenerate muscle after repeated injury.
Researchers at Heidelberg University developed a novel technique to create more complex organoids by controlling the release of growth factors and signaling molecules. This breakthrough enables the formation of realistic cell mixes, mimicking natural tissues and opening up new possibilities for engineering improved cellular complexity.
Holotomography offers a promising approach to biomedical research, providing high-resolution images of live cells and tissues at the organelle level. The KAIST research team has developed core technologies and demonstrated its applications in various fields, including regenerative medicine and cancer research.
Researchers found that Chlamydia bacteria can persist in the intestines of humans, where they form a permanent reservoir and evade antibiotic treatment. The bacteria preferentially infect the inner cell layer of intestinal organoids, but not the outer epithelial layer.
Researchers have successfully infected gastrointestinal epithelial cells with Chlamydia trachomatis using lab-grown human organoids. This finding supports the theory that Chlamydia can form a reservoir in the human gut, highlighting the importance of further investigation into this potential reservoir.
A study published in Nature Communications implicates the gene CHCHD2 in Huntington's disease progression and identifies it as a potential therapeutic target. The researchers found that mutations in the HTT gene affect CHCHD2, which is involved in maintaining mitochondrial function.
A study of over 900 children with autism spectrum disorder found that brain overgrowth is associated with increased social and communication symptoms. The research used MRI brain images and mini-brain experiments to show that enlarged brains are linked to altered Ndel1 enzyme activity, potentially affecting brain development.
Organoids models provide a comprehensive understanding of gastrointestinal disease etiology, highlighting complex interactions between genetic predisposition and gut microbiota. The review demonstrates the application of organoid models from bench to clinic for simulating host-microbial interactions and developing treatment strategies.
Researchers found anomalies in embryonic development of individuals with spinal muscular atrophy (SMA), which could lead to new treatment options. These abnormalities were recreated in laboratory-grown tissue cultures called organoids, revealing key insights into the disease's progression.
Human lung organoids can form lifelike models for tuberculosis infection, enabling the testing of anti-tuberculosis drugs. These models may also facilitate the development of host-directed therapies.
Researchers found that epalrestat increased sensitivity of non-small cell lung cancer tumors to chemotherapy, making it more effective. The study used patient-derived tumor organoids and found that overexpression of AKR1B10 was linked to drug resistance.
Bioethicist Insoo Hyun argues that advances in organoids and embryonic models strengthen rather than weaken the concept of human individuality. Current technologies are unable to replicate sentience, a crucial aspect of personhood, until major innovations are made.
Researchers at IBEC successfully generated kidney organoids with a complex vascular system, a breakthrough that could revolutionize disease modeling and drug screening. This achievement was made possible by combining 3D kidney organoids with endothelial organoids in a process that mimics the development of human kidneys.
Researchers developed a novel approach using intestinal organoids to study gastrointestinal motility. They found EEC stiffness values ranging from 60 to 70 pN/μm and demonstrated changes in EEC stiffness upon TDO2 inhibition.
Researchers from IBEC investigated how mechanical properties of colorectal cancer stem cells influence metastasis. Cells expressing LGR5 protein exhibit softer, less sticky properties and better adhere to blood vessel walls.
Researchers used human lung microtissues to uncover the strategy used by Pseudomonas aeruginosa to invade lungs. The pathogen targets goblet cells, which it uses as Trojan horses to breach the defense line. Lung organoids also enabled the development of a sensor to monitor bacteria and track their behavior during infection.
Researchers have created the world's first human mini-brain that incorporates a fully functional blood-brain barrier, mimicking human neurovascular development. This breakthrough model promises to accelerate understanding and treatment of brain disorders like stroke, cerebral vascular disorders, and Parkinson's disease.
The Gilbert Family Foundation has invested $21 million in grants to launch the Next-Generation NF1 Models Initiative, a research program focused on developing advanced models of the NF1 disease. The initiative aims to accelerate the discovery of treatments that address both symptoms and underlying causes of neurofibromatosis.
A new NIH study using human cerebral organoids suggests a substantial species barrier preventing the transmission of chronic wasting disease from cervids to people. Researchers found no infection in healthy human cerebral organoids exposed to CWD prions for up to six months.
A University of Saskatchewan researcher is building tiny pseudo-organs from stem cells to help diagnose and treat Alzheimer's disease. These 'mini-brains' more accurately reflect a fully-fledged adult human brain, allowing for closer examination of neurological conditions.
Researchers have discovered a small molecule compound called ESI1 that can regenerate vital myelin coatings, potentially treating multiple sclerosis and age-related cognitive deficits. The treatment promotes healing by clearing a roadblock in the repair process, allowing oligodendrocytes to produce myelin sheaths.
Researchers have developed a new organoid model to study the thymus and its function in training T cells. The model enables long-term culture of TECs, which could lead to new insights into treating patients with impaired thymus function.
Researchers developed a gene-based therapy that restored typical cellular function in organoids created from cells of people with Timothy syndrome. The treatment used antisense oligonucleotides to decrease the use of mutated exon 8A and increase reliance on non-affected exon 8, restoring normal calcium channel functioning.
Researchers at Stanford Medicine have developed brain organoids and assembloids to study neurodevelopmental disorders such as autism and schizophrenia. These three-dimensional models can survive for several years in culture, enabling scientists to view the developing human brain up close and in real time.
Scientists have developed mini-colon tissues that can simulate the complex process of tumorigenesis outside the body with high fidelity. These miniature organs mimic the physical structure and cellular diversity of colon tissue, allowing researchers to study colorectal cancer development and test potential therapies.
Researchers have shed light on the complex communication between cells at the gastro-esophageal junction, revealing specific pathways and cellular composition. The study provides new starting points for understanding, preventing, and treating gastrointestinal diseases.
Researchers have gained new insights into the development of cells, their communication with each other, and regulation at the gastro-esophageal junction. The study reveals complex cellular communication and signaling pathways, which has significant implications for understanding, preventing, and treating gastrointestinal diseases.
Researchers at The University of Tokyo successfully connected lab-grown brain-mimicking tissue using axonal bundles, mimicking natural brain connections. This breakthrough enables the study of complex brain networks and their role in various neurological and psychiatric conditions.
Researchers at the University of Montana have found a novel method to generate human cartilage using neural crest cells. This breakthrough could lead to effective treatments for repairing craniofacial cartilage damage and improving the lives of 230,000 children born annually with craniofacial defects.